Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Cue Biopharma to Present at the 2021 Frontiers in Cancer Immunotherapy Conference
Cue Biopharma, Inc.May 6, 2021 GMT
CAMBRIDGE, Mass., May 06, 2021 (GLOBE NEWSWIRE) Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company engineering a novel class of injectable biologics designed to selectively engage and modulate targeted T cells directly within the patient’s body, announced today it will give a poster presentation at the New York Academy of Sciences 2021 Frontiers in Cancer Immunotherapy meeting, which is being held virtually from May 12-14, 2021. The presentation will highlight clinical and preclinical data supporting the mechanism of action (MOA) for the Immuno-STAT™